Rainer M Erdtmann - Net Worth and Insider Trading

Rainer M Erdtmann Net Worth

The estimated net worth of Rainer M Erdtmann is at least $39 Million dollars as of 2024-11-13. Rainer M Erdtmann is the President & COO, 10% Owner of Biomea Fusion Inc and owns about 4,922,191 shares of Biomea Fusion Inc (BMEA) stock worth over $39 Million. Rainer M Erdtmann is also the Director of Regenetp Inc and owns about 2,000 shares of Regenetp Inc (RGTPQ) stock worth over $242. Details can be seen in Rainer M Erdtmann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rainer M Erdtmann has not made any transactions after 2021-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rainer M Erdtmann

To

Rainer M Erdtmann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rainer M Erdtmann owns 3 companies in total, including Summit Therapeutics Inc (SMMT) , Regenetp Inc (RGTPQ) , and Biomea Fusion Inc (BMEA) .

Click here to see the complete history of Rainer M Erdtmann’s form 4 insider trades.

Insider Ownership Summary of Rainer M Erdtmann

Ticker Comapny Transaction Date Type of Owner
SMMT Summit Therapeutics Inc 2020-09-18 director
RGTPQ Regenetp Inc 2019-12-16 director
BMEA Biomea Fusion Inc 2021-08-23 director & 10 percent owner & President and COO

Rainer M Erdtmann Latest Holdings Summary

Rainer M Erdtmann currently owns a total of 2 stocks. Among these stocks, Rainer M Erdtmann owns 4,922,191 shares of Biomea Fusion Inc (BMEA) as of August 23, 2021, with a value of $39 Million and a weighting of 100%. Rainer M Erdtmann also owns 2,000 shares of Regenetp Inc (RGTPQ) as of December 16, 2019, with a value of $242 and a weighting of 0%.

Latest Holdings of Rainer M Erdtmann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMEA Biomea Fusion Inc 2021-08-23 4,922,191 8.01 39,426,750
RGTPQ Regenetp Inc 2019-12-16 2,000 0.12 242

Holding Weightings of Rainer M Erdtmann


Rainer M Erdtmann Form 4 Trading Tracker

According to the SEC Form 4 filings, Rainer M Erdtmann has made a total of 3 transactions in Biomea Fusion Inc (BMEA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biomea Fusion Inc is the acquisition of 24,000 shares on August 23, 2021, which cost Rainer M Erdtmann around $316,800.

According to the SEC Form 4 filings, Rainer M Erdtmann has made a total of 1 transactions in Regenetp Inc (RGTPQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Regenetp Inc is the sale of 1,274 shares on December 16, 2019, which brought Rainer M Erdtmann around $78,660.

Insider Trading History of Rainer M Erdtmann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rainer M Erdtmann Trading Performance

GuruFocus tracks the stock performance after each of Rainer M Erdtmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rainer M Erdtmann is -7.92%. GuruFocus also compares Rainer M Erdtmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rainer M Erdtmann within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rainer M Erdtmann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rainer M Erdtmann

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Rainer M Erdtmann Ownership Network

Ownership Network List of Rainer M Erdtmann

No Data

Ownership Network Relation of Rainer M Erdtmann

Insider Network Chart

Rainer M Erdtmann Owned Company Details

What does Summit Therapeutics Inc do?

Who are the key executives at Summit Therapeutics Inc?

Rainer M Erdtmann is the director of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , director & 10 percent owner & See Remarks Robert W Duggan , and VP & Corporate Controller Jeffrey R Maranian .

Summit Therapeutics Inc (SMMT) Insider Trades Summary

Over the past 18 months, Rainer M Erdtmann made no insider transaction in Summit Therapeutics Inc (SMMT). Other recent insider transactions involving Summit Therapeutics Inc (SMMT) include a net purchase of 120,400 shares made by Ankur Dhingra , a net purchase of 115,321 shares made by Maky Zanganeh , and a net purchase of 2,976,190 shares made by Manmeet Singh Soni .

In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc (SMMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc (SMMT) were sold and 3,211,911 shares were bought by its insiders, resulting in a net purchase of 3,211,911 shares.

Summit Therapeutics Inc (SMMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Summit Therapeutics Inc Insider Transactions

No Available Data

Rainer M Erdtmann Mailing Address

Above is the net worth, insider trading, and ownership report for Rainer M Erdtmann. You might contact Rainer M Erdtmann via mailing address: 1073 Arlington Blvd., El Cerrito Ca 94530.